Literature DB >> 21233431

Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission.

Seth C Kalichman1, Chauncey Cherry, Moira O Kalichman, Christina M Amaral, Denise White, Howard Pope, Connie Swetzes, Lisa Eaton, Rene Macy, Demetria Cain.   

Abstract

OBJECTIVES: We conducted a randomized clinical trial to test an integrated behavioral intervention designed to enhance using HIV treatment as prevention by improving medication adherence, reducing risks for other sexually transmitted infections, and minimizing risk compensation beliefs.
METHODS: Individuals living with HIV/AIDS (n = 436) participated in a randomized clinical trial testing an intensive behavioral intervention aimed at reducing HIV transmission risks compared with an attention control condition. We used unannounced pill counts to monitor antiretroviral therapy adherence and computerized interviews to measure risk behaviors.
RESULTS: The integrated transmission risk reduction intervention demonstrated increased antiretroviral therapy adherence and less unprotected intercourse with nonseroconcordant partners at 3- and 6-month follow-ups as well as fewer new sexually transmitted infections diagnosed over the 9-month follow-up period (adjusted odds ratio = 3.0; P < .05; 95% confidence interval = 1.01, 9.04). The integrated intervention also reduced behavioral risk compensation beliefs.
CONCLUSIONS: A theory-based integrated behavioral intervention can improve HIV treatment adherence and reduce HIV transmission risks. HIV treatment as prevention should be bundled with behavioral interventions to maximize effectiveness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233431      PMCID: PMC3036694          DOI: 10.2105/AJPH.2010.197608

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  40 in total

1.  Viral load, perceived infectivity, and unprotected intercourse.

Authors:  S C Kalichman; D Rompa; J Austin; W Luke; K DiFonzo
Journal:  J Acquir Immune Defic Syndr       Date:  2001-11-01       Impact factor: 3.731

2.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Authors:  Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum
Journal:  Lancet       Date:  2010-05-26       Impact factor: 79.321

3.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

4.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

5.  Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen.

Authors:  L H Ping; M S Cohen; I Hoffman; P Vernazza; F Seillier-Moiseiwitsch; H Chakraborty; P Kazembe; D Zimba; M Maida; S A Fiscus; J J Eron; R Swanstrom; J A Nelson
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Sexually transmitted infections among HIV seropositive men and women.

Authors:  S C Kalichman; D Rompa; M Cage
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

7.  The impact of T-ACASI interviewing on reported drug use among men who have sex with men.

Authors:  J N Gribble; H G Miller; P C Cooley; J A Catania; L Pollack; C F Turner
Journal:  Subst Use Misuse       Date:  2000 May-Jun       Impact factor: 2.164

8.  Use of a public sexually transmitted disease clinic by known HIV-positive adults: decreased self-reported risk behavior and increased disease incidence.

Authors:  Toye Helena Brewer; Lisa R Metsch; Jonathon M Zenilman
Journal:  J Acquir Immune Defic Syndr       Date:  2002-03-01       Impact factor: 3.731

9.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

Authors:  S L Catz; J A Kelly; L M Bogart; E G Benotsch; T L McAuliffe
Journal:  Health Psychol       Date:  2000-03       Impact factor: 4.267

10.  HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy.

Authors:  S C Kalichman; D Rompa
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

View more
  41 in total

1.  Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Authors:  Marya Gwadz; Charles M Cleland; Elizabeth Applegate; Mindy Belkin; Monica Gandhi; Nadim Salomon; Angela Banfield; Noelle Leonard; Marion Riedel; Hannah Wolfe; Isaiah Pickens; Kelly Bolger; DeShannon Bowens; David Perlman; Donna Mildvan
Journal:  AIDS Behav       Date:  2015-10

2.  Comparison of HIV outcomes for patients linked at hospital versus community-based clinics.

Authors:  Asher J Schranz; Kathleen A Brady; Florence Momplaisir; Joshua P Metlay; Alisa Stephens; Baligh R Yehia
Journal:  AIDS Patient Care STDS       Date:  2015-02-09       Impact factor: 5.078

Review 3.  Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Authors:  Kartik K Venkatesh; Timothy P Flanigan; Kenneth H Mayer
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

4.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

Review 5.  A systematic review of interventions for reducing HIV risk behaviors among people living with HIV in the United States, 1988-2012.

Authors:  Nicole Crepaz; Malu V Tungol-Ashmon; Darrel H Higa; Waverly Vosburgh; Mary M Mullins; Terrika Barham; Adebukola Adegbite; Julia B DeLuca; Theresa A Sipe; Christina M White; Brittney N Baack; Cynthia M Lyles
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

Review 6.  Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

Authors:  Sonali P Kulkarni; Kavita R Shah; Karthik V Sarma; Anish P Mahajan
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

7.  Sexual Behaviors and Transmission Risks Among People Living with HIV: Beliefs, Perceptions, and Challenges to Using Treatments as Prevention.

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Christopher Washington; Tamar Grebler; Ginger Hoyt; Cindy Merely; Brandi Welles
Journal:  Arch Sex Behav       Date:  2015-08-21

Review 8.  Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Authors:  Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell
Journal:  AIDS Behav       Date:  2014-04

Review 9.  Assessing the role of masculinity in the transmission of HIV: a systematic review to inform HIV risk reduction counseling interventions for men who have sex with men.

Authors:  Robert J Zeglin
Journal:  Arch Sex Behav       Date:  2015-04-28

10.  Understanding HIV-Related Pill Aversion as a Distinct Barrier to Medication Adherence.

Authors:  Robin M Dorman; Sarah H Sutton; Lynn M Yee
Journal:  Behav Med       Date:  2019-01-03       Impact factor: 3.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.